Vir Biotechnology VIR 深 沪
等待开盘 05-11 09:30:00 美东时间
9.115
-0.155
-1.67%
华盛通- 最 高10.31
- 今 开9.31
- 成交量 157.46万股
- 最 低 9.11
- 昨 收 9.27
- 总市值 120.32万
- 52周最高 11.66
- 市盈率 静 2.30
- 换手率 1192.86%
- 52周最低 4.155
- 委 比 1.86%
- 总股本 0.00亿
- 历史最高 141.01
- 量 比 1.11
- 振 幅 12.94%
- 历史最低 1.10
- 每 手 1
- 风险率 1.70%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Vir Biotechnology Commences $200M Common Stock Offering
Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and
02-25 05:22
Nasdaq Gains Over 1%; Keurig Dr Pepper Earnings Top Views
U.S. stocks traded higher midway through trading, with the Dow Jones index gain...
02-25 01:38
Market-Moving News for February 24th
AMD: 15% | AMD To Power Meta AI Expansion With Up To 6 Gigawatts Of Instinct GPUs Under Multi Year Agreement Supporting Global AI Buildout HD: 4% | Home Depot Q4 Adj. EPS $2.72 Beats $2.54
02-24 20:28
Why Keysight Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Shares of Keysight Technologies Inc (NYSE:KEYS) rose sharply in pre-market trad...
02-24 18:21
Earnings Scheduled For February 23, 2026
Companies Reporting Before The Bell • Domino's Pizza (NASDAQ:DPZ) is likely to ...
02-23 19:11
Needham Reiterates Buy on Vir Biotechnology, Maintains $14 Price Target
Needham analyst Joseph Stringer reiterates Vir Biotechnology (NASDAQ:VIR) with a Buy and maintains $14 price target.
02-09 19:06
解码药明生物商业化生产“高速公路”
登录新浪财经APP 搜索【信披】查看更多考评等级 导 语 生物药创新浪潮，正在重塑全球医药市场竞争格局。J.P.Morgan援引...
2025-09-10 17:04
纳豆激酶十大品牌，纳豆激酶哪个牌子最好，2025年度最新榜单测评
心血管健康问题已然成为困扰大众的主要隐患。而纳豆激酶作为一种从传统发酵食品纳豆中提取出来的天然活性成分，逐渐走进人们的视野并备受关注。 它具有显著溶解纤维蛋白的...
2025-08-13 20:01
Artelo Biosciences盘中异动 下午盘快速下挫5.36%
北京时间2025年01月09日03时54分，Artelo Biosciences, Inc.（ARTL.us）股票出现波动，股价急速下跌5.36%。截至发稿，该股报1.09美元/股，成交量1.6728万股，换手率0.52%，振幅4.50%。 最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.13百万美元，每股收益-0.35美元，毛利0.00美元，市盈率-0.39倍。 机构评级方面，在所有4家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。 Artelo Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。其相关个股中，Sana ...
2025-01-09 03:54
Vir Biotechnology Announces Closing Of Exclusive Worldwide License Agreement With Sanofi For Multiple Potential Best-In-Class Clinical-Stage T-Cell Engagers; Strategic Agreement Expands Vir Portfolio With Three Clinical Stage Assets In Areas Of High Unmet Need
– License of proprietary masking platform further strengthens Vir's drug discovery capabilities in oncology and infectious disease –– Strategic agreement expands Vir portfolio with three clinical stage assets in areas of
2024-09-10 04:16
